{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for irinotecan in Note (approximate match)
Showing 1 - 8 of 8 results
Status:
US Approved Rx
(2008)
Source:
ANDA077915
(2008)
Source URL:
First approved in 1996
Source:
NDA020571
Source URL:
Class (Stereo):
CHEMICAL (ABSOLUTE)
Targets:
Conditions:
Irinotecan is an antineoplastic enzyme inhibitor primarily used in the treatment of colorectal cancer. Irinotecan is sold under the brand name Camptosar among others. CAMPTOSAR is a topoisomerase inhibitor indicated for:
• First-line therapy in combination with 5-fluorouracil and leucovorin for
patients with metastatic carcinoma of the colon or rectum.
• Patients with metastatic carcinoma of the colon or rectum whose disease
has recurred or progressed following initial fluorouracil-based therapy.
Irinotecan is a derivative of camptothecin. Camptothecins interact specifically with the enzyme
topoisomerase I, which relieves torsional strain in DNA by inducing reversible single-strand
breaks. Irinotecan and its active metabolite SN-38 bind to the topoisomerase I-DNA complex
and prevent religation of these single-strand breaks. Current research suggests that the
cytotoxicity of irinotecan is due to double-strand DNA damage produced during DNA synthesis
when replication enzymes interact with the ternary complex formed by topoisomerase I, DNA,
and either irinotecan or SN-38. Mammalian cells cannot efficiently repair these double-strand
breaks.
Status:
Possibly Marketed Outside US
Source:
ANDA070433
(1987)
Source URL:
First approved in 1987
Source:
ANDA070433
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Water O-15 as a diagnostic agent that was used in H215O-positron emission tomography/magnetic resonance imaging for noninvasive measurement of cerebral blood flow.
Status:
Possibly Marketed Outside US
Source:
21 CFR 333A
(2018)
Source URL:
First approved in 1978
Source:
K-PhosNo. 2 by Beach Products, Inc.
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Status:
Possibly Marketed Outside US
Source:
NCT01290055: Phase 4 Interventional Completed Yellow Fever
(2019)
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Deuterium Oxide (heavy water) is a stable, non-radioactive isotopic form of water. The heavy water is used as a moderator of neutrons in nuclear power plants. In the laboratory, heavy water is employed as an isotopic tracer in studies of chemical and biochemical processes. Deuterium oxide acts as a true temperature-modifying agent. It protects mammalian cells against hyperthermic damage. Plant cell biologists had made a similar observation. Regarding human health, deuterium oxide has a wide range of proposed applications, such as therapeutic agent against human pancreatic cancer, determination of total body water (TBW), and enhancement of thermal stability of macromolecules, cells and tissue. Other applications are: treatment of hypertension, treatment of virus-based diseases of the respiratory tract and treatment of herpes virus-based diseases of the skin.
Status:
US Approved Rx
(2008)
Source:
ANDA077915
(2008)
Source URL:
First approved in 1996
Source:
NDA020571
Source URL:
Class (Stereo):
CHEMICAL (ABSOLUTE)
Targets:
Conditions:
Irinotecan is an antineoplastic enzyme inhibitor primarily used in the treatment of colorectal cancer. Irinotecan is sold under the brand name Camptosar among others. CAMPTOSAR is a topoisomerase inhibitor indicated for:
• First-line therapy in combination with 5-fluorouracil and leucovorin for
patients with metastatic carcinoma of the colon or rectum.
• Patients with metastatic carcinoma of the colon or rectum whose disease
has recurred or progressed following initial fluorouracil-based therapy.
Irinotecan is a derivative of camptothecin. Camptothecins interact specifically with the enzyme
topoisomerase I, which relieves torsional strain in DNA by inducing reversible single-strand
breaks. Irinotecan and its active metabolite SN-38 bind to the topoisomerase I-DNA complex
and prevent religation of these single-strand breaks. Current research suggests that the
cytotoxicity of irinotecan is due to double-strand DNA damage produced during DNA synthesis
when replication enzymes interact with the ternary complex formed by topoisomerase I, DNA,
and either irinotecan or SN-38. Mammalian cells cannot efficiently repair these double-strand
breaks.
Status:
US Approved OTC
Source:
21 CFR 349.2 ophthalmic:eyewash water, purified
Source URL:
First marketed in 1921
Class (Stereo):
CHEMICAL (ACHIRAL)
Sodium is the primary cation (positive ion) in extracellular fluids in animals and humans. Sodium ions are necessary for regulation of blood and body fluids, transmission of nerve impulses, heart activity, and certain metabolic functions. Physiologically, it exists as an ion in the body. Sodium is needed by animals, which maintain high concentrations in their blood and extracellular fluids, but the ion is not needed by plants. The human requirement for sodium in the diet is less than 500 mg per day, which is typically less than a tenth as much as many diets "seasoned to taste. " Most people consume far more sodium than is physiologically needed. For certain people with salt-sensitive blood pressure, this extra intake may cause a negative effect on health.